Cellect Biotechnology Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating income was ILS 4.179 million compared to ILS 3.480 million a year ago. Net loss was ILS 5.579 million compared to ILS 8.804 million a year ago. Basic loss per share from continuing operations was ILS 0.014 compared to ILS 0.024 a year ago. For the half year, operating income was ILS 8.677 million compared to ILS 7.604 million a year ago. Net loss was ILS 9.845 million compared to ILS 11.356 million a year ago. Basic loss per share from continuing operations was ILS 0.025 compared to ILS 0.034 a year ago.